Loading quotes...
Forecast
There is no analyst data available for this company.
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | September 2026 | YoY |
|---|---|---|
| Revenue | 41.44m | 4.34% |
| Gross profit | 34.71m | 764.06% |
| Net profit | 41.06m | 183.27% |
| EBITDA | 66.51m | 94.40% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €459.5m |
Number of shares | 37.6m |
52-week high/low | €12.55 - €9.53 |
Dividend yield | 3.06% |
Dividends TTM | €0.37 |
Beta | 0.63 |
P/E ratio | 12.30 |
PEG ratio | 0.04 |
P/B ratio | 1.56 |
P/S ratio | 3.65 |
Company profile
DRI Healthcare Trust focuses on managing and growing a portfolio of pharmaceutical royalties. It owns a portfolio of 18 royalties derived from the sale of 14 various pharmaceutical products that focuses on eight therapeutic areas. The company was incorporated in 2020 and is headquartered in Toronto, Canada.
| Name | DRI HEALTHCARE UNIT TRUST |
| CEO | Gary Collins |
| Headquarters | Toronto,
on Canada |
| Website | |
| IPO | 11/02/2021 |
| Employees | 32 |
Deep Dive
Ticker symbols
| Exchange | Symbol |
|---|---|
Toronto Stock Exchange | DHT-UN.TO |
Frankfurt | 3IJ0.F |